External Funding Opportunities
Federal
The United States Department of Defense
The National Institutes of Health
Building Interdisciplinary Research Careers in Women's Health
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-05-002.html
RFA Number: RFA-OD-05-002
Release Date: November 24, 2004
Letters of Intent Receipt Date(s): January 22, 2005
Application Receipt Date(s): February 23, 2005
Peer Review Date(s): June/July 2005
Council Review Date(s): September 2005
Earliest Anticipated Start Date: September 30, 2005
Executive Summary
The NIH Office of Research on Women's Health (ORWH) and its cosponsors invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Career Development Programs, hereafter termed "Programs." Programs will support research career development of junior faculty members, known as Interdisciplinary Women's Health Research (IWHR) Scholars, who have recently completed clinical training or postdoctoral fellowships, and who are commencing basic, translational, behavioral, clinical and/or health services research relevant to women's health.
The goal of this initiative is to promote the performance of interdisciplinary research and transfer of findings that will benefit the health of women, including sex/gender similarities or differences in biology, health or disease. The programs will accomplish these goals by bridging advanced training with research independence, as well as bridging scientific disciplines or areas of interest. This will increase the number and skills of investigators at awardee institutions through a mentored research and career development experience leading to an independent interdisciplinary scientific career addressing women's health.
The NIH Institutes and Centers support biomedical and behavioral research and research training. The Agency for Healthcare Research and Quality (AHRQ) supports health services research and research training. The cosponsors are partnering with ORWH to support the career development of researchers in women's health within their respective missions.
Non Federal
Alliance for Cancer Gene Therapy Announces Request for Applications
Deadline: February 23, 2005
The Alliance for Cancer Gene Therapy funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer.
As part of this mission, AGCT invites applications for its 2005 ACGT Gene Therapy for Lymphoma & Leukemia Award pro- gram. The overall objectives of the program are to advance gene therapy into the causes, treatment, and prevention of lymphoma and leukemia by promoting basic, pre-clinical and clinical translational research approaches utilizing cells and genes as medicine. ACGT will direct the awards to gene therapy research that has demonstrated great promise, particularly those that are closer to clinical translation.
Candidates for the Gene Therapy for Lymphoma & Leukemia Award must hold an M.D., Ph.D., or equivalent degree and be a tenure-track or tenured faculty. The investigator must also be conducting original research as an indepen- dent faculty member. Although there are no citizenship restrictions, research supported by the award must be conducted at medical schools and research centers in the United States.
Grants of up to $1 million will be awarded over a period of three to five years (inclusive of a maximum of 10 percent indirect costs).
Visit the AGCT Web site to download the complete Request for Applications.
RFP Link: http://acgtfoundation.org/
For additional RFPs in Medical Research, visit: http://fdncenter.org/pnd/rfp/cat_medical_research.jhtml
Leukemia & Lymphoma Society Invites Applications for Translational Research Program
Deadline: March 1, 2005 (Preliminary application)
The Leukemia & Lymphoma Society ( http://www.lls.org/ ), a national health organization that sponsors research on leukemia, lymphoma, and myeloma, announces a call for preliminary applications for its Translational Research Program.
The program is designed to encourage and provide early- stage support for clinical research in leukemia, lymphoma, and myeloma that leads to the development of innovative approaches to treatment, diagnosis, and/or prevention. The program also fosters collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life.
Applications proposing novel approaches to the prevention, diagnosis, or treatment of leukemia, lymphoma, and myeloma are especially welcome. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.
The program is intended to provide support over an initial three-year period. In certain instances, funding for two additional years may be available.
Awards will be limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $20,000, or 11.1 percent of direct costs, per year, for three years.
See the Leukemia & Lymphoma Society Web site for complete program information and application procedures.
RFP Link: http://fconline.fdncenter.org/pnd/527/lls
For additional RFPs in Medical Research, visit: http://fdncenter.org/pnd/rfp/cat_medical.jhtml
Fellowship Award - Damon Runyon Cancer Research Foundation
Deadline 3/15/05. This postdoctoral fellowship encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. For more information, visit the sponsor's website at: http://www.drcrf.org/apFellowship.html
Association for International Cancer Research
Internet Address: http://www.aicr.org.uk/information.stm
Health Topic Areas: Cancer research
Eligible Applicants: The application must come from a suitably qualified researcher (minimum of PhD). PhD students are only funded from within a project grant.
Description: AICR's aim is to support fundamental research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. The emphasis is on basic, as opposed to clinical research.
Application Deadline: April 29, 2005; October 28, 2005
Contact Information:
AICR Grants Administration Office
Madras House
St Andrews, Fife, KY16 9EH
Tel: (01334) 477-910
Fax: (01334) 478-667
E-mail: alan.gilchrist@aicr.org.uk
Paul Marks Prize in Cancer Research
Deadline: April 29, 2005
The Memorial Sloan-Kettering Cancer Center is seeking nominations for the 2005 Paul Marks Prize in Cancer Research. The award recognizes investigators who have made significant contributions to understanding cancer or improving the treatment of cancer through basic or clinical research. The award consists of $150,000 and the deadline is April 29, 2005.
For more information, please visit the sponsor's website at: http://www.mskcc.org/mskcc/html/53983.cfm
This award does not require internal review, please apply directly to the sponsor. For a listing of other current funding opportunities, please visit our website at http://research.bcm.tmc.edu/award.htm